Virax Biolabs Group Limited reported earnings results for the half year ended September 30, 2022. For the half year, the company reported sales was USD 0.00576 million. Net loss was USD 1.44 million compared to USD 0.552416 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8395 USD | +7.13% | +4.94% | -42.50% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.50% | 1.85M | |
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |
- Stock Market
- Equities
- VRAX Stock
- News Virax Biolabs Group Limited
- Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2022